LPL Financial’s Humacyte Inc Warrant HUMAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7K Buy
259,615
+500
+0.2% +$57 ﹤0.01% 5858
2025
Q4
$24.3K Hold
259,115
﹤0.01% 5794
2025
Q3
$68.9K Hold
259,115
﹤0.01% 5589
2025
Q2
$101K Sell
259,115
-20,000
-7% -$8.68K ﹤0.01% 5262
2025
Q1
$103K Sell
279,115
-19,365
-6% -$24.1K ﹤0.01% 5035
2024
Q4
$543K Sell
298,480
-2,119
-0.7% -$3.76K ﹤0.01% 4027
2024
Q3
$540K Hold
300,599
﹤0.01% 3927
2024
Q2
$418K Buy
300,599
+20,000
+7% +$24.8K ﹤0.01% 4014
2024
Q1
$168K Buy
280,599
+31,508
+13% +$19.6K ﹤0.01% 4544
2023
Q4
$104K Sell
249,091
-13,366
-5% -$6.57K ﹤0.01% 4543
2023
Q3
$155K Buy
262,457
+12,000
+5% +$9.37K ﹤0.01% 4319
2023
Q2
$183K Buy
250,457
+11,000
+5% +$8.89K ﹤0.01% 4179
2023
Q1
$144K Buy
239,457
+15,801
+7% +$9.42K ﹤0.01% 4131
2022
Q4
$87.8K Buy
223,656
+30,000
+15% +$26.5K ﹤0.01% 4195
2022
Q3
$213K Hold
193,656
﹤0.01% 3879
2022
Q2
$170K Buy
+193,656
New +$297K ﹤0.01% 4002
2022
Q1
Sell
-149,792
Closed -$342K 4291
2021
Q4
$342K Buy
149,792
+119,792
+399% +$350K ﹤0.01% 3593
2021
Q3
$87K Buy
+30,000
New +$87.9K ﹤0.01% 4171

Other funds holding HUMAW

LPL Financial's HUMAW Position: Q1 2026 in Review

LPL Financial increased its Humacyte Inc Warrant (HUMAW) stake by 0.19% in Q1 2026, buying an estimated $57 and bringing the position to 259,615 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5858.

LPL Financial first reported a position in HUMAW in Q3 2021 and has held it in 18 quarters since. The position peaked at $543K in Q4 2024. 7 funds tracked by Wall St. Rank hold HUMAW as of Q1 2026.

  • LPL Financial held 259,615 shares of Humacyte Inc Warrant worth $23.7K as of Q1 2026.
  • LPL Financial bought 500 Humacyte Inc Warrant shares in Q1 2026, an estimated $57.
  • Humacyte Inc Warrant made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5858 holding.
  • LPL Financial first reported a position in Humacyte Inc Warrant in Q3 2021 and has held it in 18 quarters since.
  • LPL Financial's Humacyte Inc Warrant position peaked at $543K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.